about
Chlorpromazine versus atypical antipsychotic drugs for schizophreniaAcetophenazine versus chlorpromazine for schizophreniaChlorpromazine versus piperacetazine for schizophreniaCurrent approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatmentsDetachment of surface membrane invagination systems by cationic amphiphilic drugsCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewChlorpromazine dose for people with schizophrenia.The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.Guideline-concordant antipsychotic use and mortality in schizophrenia.Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in miceDose equivalents for second-generation antipsychotics: the minimum effective dose method.Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs.Chlorpromazine versus metiapine for schizophrenia.Chlorpromazine versus clotiapine for schizophrenia.Short-Term Effects of Chlorpromazine on Oxidative Stress in Erythrocyte Functionality: Activation of Metabolism and Membrane PerturbationAntipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy.
P2860
Q24185922-8B1A248C-53AD-488B-A47E-7B80E64D2CADQ24186800-02076E63-1193-494A-8F06-A09B7AC7F59CQ24187611-30BD55DD-5C63-4C6C-B317-2DE3CAE22EC4Q27003099-5DF16CDB-DFBD-4271-82F7-91F2B72B96A5Q27303178-A44C5598-6EE4-4091-A567-B192F5631310Q28079821-1920AAD5-34D3-4D98-9769-CA231CE0B60AQ34681498-B4929E6C-812F-4AB2-B1F8-F4C7944A74C7Q35825226-0B0B355F-E704-45CA-BC1D-2BE426357896Q37131022-FF94A24B-1FA6-46E4-A2FF-2662075FAA09Q37361104-EFCD3DB9-9932-46BF-96BF-8EDDE5FA59DCQ37598284-0B3F81B4-8654-4A88-9D53-340E74393D08Q37937746-2949190B-7DBB-43DA-A9A2-3D3BB0767223Q38738714-011CD9F2-D7C7-4EBC-AC65-66D5AEF28050Q38848057-A10FA278-D1A0-4F3A-A2F7-455F727206C8Q40600621-D726BA38-2858-4B61-8D6A-0A9F556160D5Q42707831-1AA84F34-69C6-41A7-A817-BC7C15CA7B69
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chlorpromazine dose for people with schizophrenia
@ast
Chlorpromazine dose for people with schizophrenia
@en
Chlorpromazine dose for people with schizophrenia
@en-gb
Chlorpromazine dose for people with schizophrenia
@nl
type
label
Chlorpromazine dose for people with schizophrenia
@ast
Chlorpromazine dose for people with schizophrenia
@en
Chlorpromazine dose for people with schizophrenia
@en-gb
Chlorpromazine dose for people with schizophrenia
@nl
prefLabel
Chlorpromazine dose for people with schizophrenia
@ast
Chlorpromazine dose for people with schizophrenia
@en
Chlorpromazine dose for people with schizophrenia
@en-gb
Chlorpromazine dose for people with schizophrenia
@nl
P2860
P3181
P1476
Chlorpromazine dose for people with schizophrenia
@en
P2093
Saskia De Haan
Xiaomeng Liu
P2860
P3181
P356
10.1002/14651858.CD007778
P577
2009-04-15T00:00:00Z